)
iBio (IBIO) investor relations material
iBio Leerink Global Healthcare Conference 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic vision and therapeutic focus
Pivoted to cardiometabolic disease, targeting areas beyond GLP-1s in obesity treatment.
Employs a portfolio approach with multiple mechanisms to de-risk development in a high-attrition field.
Focuses on innovative antibody therapies, particularly targeting Activin E, and aims to address unmet needs in obesity and related diseases.
Sees opportunities in combination therapies with GLP-1s and potential for weight maintenance indications.
Considers expanding into related areas such as Type 2 diabetes, MASH, cardiovascular disease, and sleep apnea.
Pipeline progress and clinical milestones
Plans to file Activin E IND by year-end, with first patient dosing in the first half of next year and possible interim data by year-end.
Bispecific myostatin/activin A program is six months behind Activin E, targeting clinic entry in the second half of next year.
Myostatin program recently filed in Australia, aiming for first patient dosing as early as Q3.
Non-human primate data for Activin E antibody aligns with recent human data, supporting translational potential.
Biomarker and inflammation data from ongoing studies will inform phase IIa design and patient selection.
Competitive differentiation and technology platform
Antibody approach targets protein in blood, aiming for near-complete pathway inhibition and potentially superior efficacy over siRNA.
Antibodies offer validated safety and scalable manufacturing advantages compared to siRNA.
AI-enabled drug discovery platform integrates in silico and traditional methods, optimizing both antibody and antigen design.
Mammalian display platform enables simultaneous optimization of developability, expression, and specificity.
Only known company with an antibody against Activin E, engineered for high developability and safety.
Next iBio earnings date
Next iBio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)